Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

• APOTEX PHARMACHEM INC.

International Classification(s)

• C07D:HETEROCYCLIC COMPOUNDS

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Buck, Matthew A	Waterloo, CA	3	1
Derdour, Lotfi	Brantford, CA	4	1
Horne, Stephen E	Burlington, CA	23	49
Murthy, Keshava K S	Ancaster, CN	2	0
Rey, Allan W	Brantford, CA	40	86
Zetina-Rocha, Carlos	Brantford, CA	7	7

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
May 10, 2011	US,7939662,B2   US7939662B2	GRANTED PATENT AS SECOND PUBLICATION
January 29, 2009	US,20090030204,A1   US20090030204A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 7939662

Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same

---

 

Legal Events